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Koma, polsspoed, bloeddruk, proteienurie, en tuip-
trekkings is vergelyk in gevalle wat met keisersnir of
konserwatief behandel is. Die gegewens in hierdie verband
word in Tabelle VII - Xl gegee.
Uit die tabelle is dit dus duidelik dat meer van die
gevalle ~at dear keisersnit verlos is, in die ernstige
eklampsie-groep geval het, en ten spyte daarvan is die
resultate vir beide moeder' en kind aan ienlik beter as
in die gevalle wat konserwatief behandel is.
Ook is die effek van pariteit in die vorms van beban-
deling vergelyk en veral in die nullipara, waar kraam
met moeite ge-induseer kan word; of, waar kraam van
'n swak tipe is, is die perinatale mortaliteit 3 keer swakker
in die konserwatiewe behandelingsgroep ([abel Xln.
Op grond van hierdie voorlopige oorsig wiI dit dus
voorkom of daar 'n baie groter plek vir keisersnit is-
onderbewig aan sekere voorwaardes - in gevalle van
eklamp ie waar die fetu nog lewe, en dat die wak
reputasie van kei er nit onder moderne toe tande, nie
gestaaf is nie!
fMARY
1. The result of treatment in 4 ca e of eclamp ia
are presented.
2. A ca e is made out for ae arean ection here
the foetus i alive and mature enough to urvive.
3. Out of 17 Cae arean section there were no maternal
deaths, and 1 child wa lost.
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TOLBUTAMIDE OVERDOSAGE AND IRREVERSIBLE CEREBRAL DAMAGE
A CASE REPORT
J. E. Cos ETT, B.Sc., M.B. (RM'D), M.R.C.P. (Lo D.), Edendale Hospital, PieIermarilzburg
Irreversible cerebral damage due to prolonged hypogly-
caemia is a well-known result of insulin overdosage. Since
tbe discovery of oral hypoglycaemic agents the possibility
bas existed that similar effects could be caused by these
drugs. Experimental evidence, however, tends to negate
this possibility.
In most laboratory animals the hypoglycaemic action of
tolbutamide is qualitative rather than quantitative. Large
doses do not proportionately increase the degree of hypo-
glycaemia. There is, however, a -difference in the sensitivity
of various species. The threshold dose in the dog is one-
tenth of that in the rabbit. l In dogs prolonged dosage in
excess of 100 mg. per kg. causes death from acute
hypoglycaemia.2
In human diabetics large doses of sulphonylurea
derivatives do not significantly increase the response,
though there have been reports of severe hypoglycaemia
in diabetic patients who have appeared to be unduly
ensitive to therapeutic doses of these drugs. McKendry3
recorded the case of an 84-year-old diabetic man who
twice developed hypoglycaemia while ~n normal doses of
tolbutamide. On the second occasion the blood sugar was
reduced to 26 mg. per 100 ml. and he succumbed to
irreversible brain damage. Coates and Robbins4 described
'hypoglycaemic shock' in an 88-year-old woman whose
blood sugar was reduced 10 8 mg. per 100 ml. by thera-
peutic doses of chlorpropamide. Camerini-Davalos et al.5
recorded 2 patients in whom moderately severe hypo-
glycaemic reactions resulted from therapy with carbuta-
mide. Seidler et al.6 had 3 patients in whom hypoglycaemia
occurred during therapy with carbutamide or tolbutamide.
One of these became unconscious. A feature of these
reported cases is that all of the hypoglycaemic reactions
developed comparatively early in the course of treatment
with oral hypoglycaemic agents. It appears also that the
tendency to hypoglycaemia may continue for everal day
following cessation of treatment.
There have been no published reports of the effects
of excessively large doses of these drug in humans. Dr.
Henry Dolger of the Mount Sinai Hospital, ew York,
had a diabetic patient who took 25 g. of tolbutamide in
one day and apparently suffered no untoward effect
apart from asthenia.7 The effects of a massive do e of
tolbutamide on a healthy subject have never been reported.
The following case is probably unique.
CASE REPORT
A 30-year-old Indian woman wa brought to the ualty
department at Edendale Hospital on a Sunday evening in
October 1959. She was deeply unconscious. Relatives tated
that she had taken an overdose of tablets which had been
supplied to her diabetic mother at this ho pital. At thi stage
the tablets were not identified. The patient's stomach was
washed out and she was given 40 ml. of a 50% gluco e
solution intravenously without any effect on her tate of con-
sciousness. She remained deeply comatose and was admitted
to hospital at 10.30 p.m. when an intravenous infusion of 5%
glucose in water was tacted. She was a well-nouri hed woman
of average weight. Her blood pressure was 120/80 mm. Hg.
There was no cyanosis and respiration was regular and normal.
Her pupils were dilated and did not react to light. The tendon
reflexes were normal. 0 other evidence of phy ical di ease
was found. The urine was normal.
During the night, because at that stage barbiturate poisoning
was considered possible, he wa given intravenous injection
of bemegride and amiphenazole. Her coma lightened slightly
and next morning she responded to painful timuli and her
pupils were maller and reacted luggisWy to light but he did
not peak. Atropine and penicillin were given becau e there
was excess bronchial ecretion. Later methylamphetamine was
administered intramuscularly in do e of 15 mg. 8-hourly. On
the morning after her admission to ho pital her blood sugar
was 103 mg. per 100 ml. Her cerebrospinal fluid, erum
electrolytes (sodium, pota ium and chloride) and blood urea
were normal.
She never regained con ciou ne s although she survived for
44 S.A. MEDICAL JOURNAL 21 January 1961
6 months. Evidence, reconstructed from that gleaned from the
patient's relatives and the hospital records, yielded the follow-
ing story: The patient's mother was a middle-aged diabetic
who was being treated with tolbutamide in a dose of 0'5 g.
(l tablet) twice daily. On the Thursday before her daughter's
admission she had attended the outpatient department and
received a month's supply of 60 tablets. She began using these
tablets on that day. She lived with her son and daughter (the
patient). Following an unhappy marriage the patient had been
deserted by her husband who had taken their children away
with him. As a result she had become depressed and had
threatened suicide several times.
During that week-end the patient had been alone at home
from Saturday afternoon at about 4.30 p.m. until she was
discovered unconscious more than 24 hours later. Her mother
and brother were closel questioned on several occasions re-
garding the possible causes of her unconsciousness. Their
first and sustained belief was that she had consumed an
overdose of the tablets which her mother took for diabetes.
This belief was strengthened by the fact that the tablets had
been available to her, and that only 12 tablets remained in
the container after she was discovered in coma. Efforts were
made to establish the possibility of any other form of
poisoning. It appeared th<lt the usual kinds of household
remedies were present in the house. These included laxatives,
aspirins, vitamin pills and potassium permanganate crystals.
None of these was missing, nor did the patient's condition
suggest poisoning by any of them. There was no insulin in
the house. 0 fire had been burning.
Subsequent Course
During the first 48 hours after admission to hospital the
patient's coma lightened slightly, she responded to painful
stimuli, her pupils reacted to light and her deep ref1eJtes were
brisk and equal. She did not speak, nor did she make any
response to questions. Blood-sugar estimations gave normal
results. She was incontinent of urine and faeces, and was
fed with a gastric tube. It became obvious that she had
suffered irreversible cerebral damage. From the first week
onwards she lay curled up in bed grinding her teeth and
uttering periodic unintelligible shrieks without provocation.
Chlorpromazine and later phenobarbitone were used as
sedatives. In many respects her condition resembled that of
a severe grade of mental defective.
As the months passed she lost much weight despite efforts
to maintain her food intake through the gastric tube. She
gradually developed a quadriplegia with exaggerated deep
reflexes and bilateral ankle clonus. Her pupils retained their
reaction to light but it appeared that she had some impairment
of vision. She continued to menstruate fairly regularly.
Examination of the cerebrospinal fluid 4 months after admis-
sion to hospital showed a slight excess of globulin but no
other abnormality. She died, after 6 months of progressive
intellectual and neurological deterioration, in April 1960.
Postmortem Findings
At the postmortem examination (performed by Dr. P.
Matthews) the body weighed 63 lb. There were flexion
deformities of the limbs and superficial ulcers over both
hips. There was a chronic ulcer, measuring 2 cm. by t cm.,
in the anterior wall of the upper third of the oesophagus.
This was presumably caused by the gastric tube. The heart,
liver and kidneys were atrophic, being about half their expected
size. The bladder showed signs of chronic infection. The
brain was oedematous and the lateral ventricles were slightly
dilated but there was no other gross lesion. Dr.J. Suskin
reported that sections of the brain showed neuronal degene-
ration and gliosis. These changes are not specific, but would
be expected following prolonged anoxia or hypoglycaemia
with survival for some time after the accident. Other organs
showed no significant changes.
DISCUSSION
Though there is no definite proof that this patient took
an overdose of tolbutamide, the circumstantial evidence
points strongly to the conclusion that she consumed 20 g.
or more of the drug about 24 hours before she was
brought to hospital. This represents a dose of approxi-
mately 330 mg. per kg. body weight. (Her weight oD.
admission was estimated to be 60 kg.) There can be no
doubt that she suffered irreversible cerebral damage with
permanent depression of higher cerebral function and
diffuse damage to the pyramidal tracts. It is difficult to
escape the conclusion that this was due to prolonged
hypoglycaemia though, unfortunately, blood was not taken
for glucose estimation before intravenous glucose was
administered: The clinical and pathological features of the
case resembled those of cerebral damage caused by anoxia
or hypoglycaemia.
Some animal experiments tend to contradict the con-
clusion that tolbutamide was responsible, but it appears
that different species vary considerably in their response
to sulphonylurea drugs. The few recorded cases of severe
hypoglycaemia due to therapeutic doses of sulphonylurea
drugs indicate that there must also be an individual
variation in response to these drugs. Since the action of
tolbutamide depends partly on the integrity of the pancreas
and its ability to seprete insulin, it is possible that large
doses in healthy subjects would have a quantitatively
different action to that in diabetics who show a response
to the drug. Furthermore it appears that the hypoglycaemic
effect is maximal after the first few doses; this is probably
due to liberation of insulin from the pancreas in excess-
ively large amounts. It is therefore likely, in the light of
present knowledge, that the cerebral damage in this pre-
viously healthy patient was caused by an overdose of
tolbutamide, probably by means of prolonged hypo-
glycaemia.
SUMMARY
A case is described in which irreversible brain damage
apparently followed a massive overdose of tolbutamide,
taken with suicidal intent. Severe hypoglycaemia has
occasionally been reported after therapeutic doses of
sulphonylurea compounds. There is no previous record of
the effect of. an overdose in a healthy person.
ADDENDUM
Since this report was submitted for publication, Locket
and BrownS have described 2 cases of coma which were
apparently caused by oral hypoglycaemic agents. In 1 case
a non-diabetic woman deliberately took an overdose of
\ tablets and died after being comatose for 96 hours.
I thank Messrs. Hoechst Pharmaceuticals (Pty.) Ltd. for
valuable information concerning the toxic effects of oral hypo-
glycaemic agents. Permission to publish this report was given
by Dr. T. M. Adnams, Medical Superintendent, Edendale
Hospital, and authority to include the postmortem findings
was given by the Chief Magistrate, Pietermaritzburg.
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